Crain Tablet 50 Units (Calidino Genase)

Adult dose

Administer orally in 3 divided doses of 30-150 I.U. per day. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients who have just experienced a cerebral hemorrhage. Additionally, since this medication contains lactose, it should not be administered to patients with genetically inherited lactose intolerance. Occasionally, hypersensitivity reactions such as skin rash or itching may occur; if these symptoms arise, use should be discontinued immediately. Rarely, rapid heartbeat may occur, so caution is advised. Gastrointestinal symptoms such as discomfort in the stomach, nausea, vomiting, decreased appetite, abdominal pain, diarrhea, or constipation may occasionally appear. Furthermore, there may be sensations of warmth, and rarely, symptoms such as headache, drowsiness, and fatigue may occur, so caution should be taken. Particularly in older individuals, as physical functions may be reduced, careful administration, including dose reduction, is necessary when using this medication.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air exposure, and it is recommended to keep it away from direct sunlight and store it at room temperature. This helps maintain the medication's effectiveness for a longer duration.

Appearance

White round enteric-coated film tablets

Package unit

30 tablets/bottle, 300 tablets/bottle